Cargando…
Analysis of the specificity of a COVID-19 antigen test in the Slovak mass testing program
AIMS: Mass antigen testing programs have been challenged because of an alleged insufficient specificity, leading to a large number of false positives. The objective of this study is to derive a lower bound of the specificity of the SD Biosensor Standard Q Ag-Test in large scale practical use. METHOD...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8320988/ https://www.ncbi.nlm.nih.gov/pubmed/34324553 http://dx.doi.org/10.1371/journal.pone.0255267 |
_version_ | 1783730744730845184 |
---|---|
author | Hledík, Michal Polechová, Jitka Beiglböck, Mathias Herdina, Anna Nele Strassl, Robert Posch, Martin |
author_facet | Hledík, Michal Polechová, Jitka Beiglböck, Mathias Herdina, Anna Nele Strassl, Robert Posch, Martin |
author_sort | Hledík, Michal |
collection | PubMed |
description | AIMS: Mass antigen testing programs have been challenged because of an alleged insufficient specificity, leading to a large number of false positives. The objective of this study is to derive a lower bound of the specificity of the SD Biosensor Standard Q Ag-Test in large scale practical use. METHODS: Based on county data from the nationwide tests for SARS-CoV-2 in Slovakia between 31.10.–1.11. 2020 we calculate a lower confidence bound for the specificity. As positive test results were not systematically verified by PCR tests, we base the lower bound on a worst case assumption, assuming all positives to be false positives. RESULTS: 3,625,332 persons from 79 counties were tested. The lowest positivity rate was observed in the county of Rožňava where 100 out of 34307 (0.29%) tests were positive. This implies a test specificity of at least 99.6% (97.5% one-sided lower confidence bound, adjusted for multiplicity). CONCLUSION: The obtained lower bound suggests a higher specificity compared to earlier studies in spite of the underlying worst case assumption and the application in a mass testing setting. The actual specificity is expected to exceed 99.6% if the prevalence in the respective regions was non-negligible at the time of testing. To our knowledge, this estimate constitutes the first bound obtained from large scale practical use of an antigen test. |
format | Online Article Text |
id | pubmed-8320988 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Public Library of Science |
record_format | MEDLINE/PubMed |
spelling | pubmed-83209882021-07-31 Analysis of the specificity of a COVID-19 antigen test in the Slovak mass testing program Hledík, Michal Polechová, Jitka Beiglböck, Mathias Herdina, Anna Nele Strassl, Robert Posch, Martin PLoS One Research Article AIMS: Mass antigen testing programs have been challenged because of an alleged insufficient specificity, leading to a large number of false positives. The objective of this study is to derive a lower bound of the specificity of the SD Biosensor Standard Q Ag-Test in large scale practical use. METHODS: Based on county data from the nationwide tests for SARS-CoV-2 in Slovakia between 31.10.–1.11. 2020 we calculate a lower confidence bound for the specificity. As positive test results were not systematically verified by PCR tests, we base the lower bound on a worst case assumption, assuming all positives to be false positives. RESULTS: 3,625,332 persons from 79 counties were tested. The lowest positivity rate was observed in the county of Rožňava where 100 out of 34307 (0.29%) tests were positive. This implies a test specificity of at least 99.6% (97.5% one-sided lower confidence bound, adjusted for multiplicity). CONCLUSION: The obtained lower bound suggests a higher specificity compared to earlier studies in spite of the underlying worst case assumption and the application in a mass testing setting. The actual specificity is expected to exceed 99.6% if the prevalence in the respective regions was non-negligible at the time of testing. To our knowledge, this estimate constitutes the first bound obtained from large scale practical use of an antigen test. Public Library of Science 2021-07-29 /pmc/articles/PMC8320988/ /pubmed/34324553 http://dx.doi.org/10.1371/journal.pone.0255267 Text en © 2021 Hledík et al https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. |
spellingShingle | Research Article Hledík, Michal Polechová, Jitka Beiglböck, Mathias Herdina, Anna Nele Strassl, Robert Posch, Martin Analysis of the specificity of a COVID-19 antigen test in the Slovak mass testing program |
title | Analysis of the specificity of a COVID-19 antigen test in the Slovak mass testing program |
title_full | Analysis of the specificity of a COVID-19 antigen test in the Slovak mass testing program |
title_fullStr | Analysis of the specificity of a COVID-19 antigen test in the Slovak mass testing program |
title_full_unstemmed | Analysis of the specificity of a COVID-19 antigen test in the Slovak mass testing program |
title_short | Analysis of the specificity of a COVID-19 antigen test in the Slovak mass testing program |
title_sort | analysis of the specificity of a covid-19 antigen test in the slovak mass testing program |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8320988/ https://www.ncbi.nlm.nih.gov/pubmed/34324553 http://dx.doi.org/10.1371/journal.pone.0255267 |
work_keys_str_mv | AT hledikmichal analysisofthespecificityofacovid19antigentestintheslovakmasstestingprogram AT polechovajitka analysisofthespecificityofacovid19antigentestintheslovakmasstestingprogram AT beiglbockmathias analysisofthespecificityofacovid19antigentestintheslovakmasstestingprogram AT herdinaannanele analysisofthespecificityofacovid19antigentestintheslovakmasstestingprogram AT strasslrobert analysisofthespecificityofacovid19antigentestintheslovakmasstestingprogram AT poschmartin analysisofthespecificityofacovid19antigentestintheslovakmasstestingprogram |